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Available online 16 March 2016Background: Subjective health status is an increasingly important parameter to assess the effect of percutaneous
coronary intervention (PCI) in clinical practice.
Aim of this study was to determine medical and psychosocial predictors of poor subjective health status over a
10 years' post-PCI period.
Methods:We included a series of consecutive PCI patients (n = 573) as part of the RESEARCH registry, a Dutch
single-center retrospective cohort study.
Results: These patients completed the 36-item Short-Form Health Survey (SF-36) at baseline and 10 years post-
PCI.We found 6 predictors of poor subjective health status 10 years post-PCI: SF-36 at baseline, age, previous PCI,
obesity, acute myocardial infarction as indication for PCI, and diabetes mellitus (arranged from most to least
numbers of sub domains).
Conclusions: SF-36 scores at baseline, age, and previous PCI were signiﬁcant predictors of subjective health status
10 years post-PCI. Speciﬁcally, the SF-36 score at baseline was an important predictor. Thus assessment of sub-
jective health status at baseline is useful as an indicator to predict long-term subjective health status. Subjective
health status becomes better by optimal medical treatment, cardiac rehabilitation and psychosocial support. This
is the ﬁrst study determining predictors of subjective health status 10 years post-PCI.






Percutaneous coronary intervention (PCI) is an effective therapy
for atherosclerotic cardiovascular disease [1]. During the last decade,
PCI has resulted in a better prognosis; it has decreased restenosis [2].
Furthermore, PCI appeared to have a positive inﬂuence on subjective
health status [3–7]. Thereafter, subjective health status became an
increasingly important parameter to assess the effect of PCI in clini-
cal practice [8–12].
Until now, a clear conceptual framework that describes speciﬁc pre-
dictors for long-term subjective health status after PCI is lacking. Only a
few studies have reported on medical and psychosocial predictors of
(subjective) health status post-PCI [13–18]. Some of these studies
found baseline subjective health status to be an important predictor of
subjective health status post-PCI. [13,14,17,18] Furthermore, age [13],edical Center, Department of
otterdam, PO box 55, 3000 WB
n Domburg).
eliability and freedom frombias
land Ltd. This is an open access artmale gender, previous coronary artery bypass grafting (CABG), renal
impairment [17], and smoking [16] were predictors of health status
post-PCI. An important limitation of these studies was the short dura-
tion of follow-up; all these studies had a follow-up of 12 months only
[13–17].
Medical and psychosocial predictors of subjective health status at
longer term are still unknown. The overall goal of this study is to bridge
this gap in knowledge and gain insight in this domain. Speciﬁcally, this
study's aim is to determinemedical and psychosocial predictors of poor
subjective health status over a 10 years period post-PCI. We hypothe-
sized that the medical predictors, as found in the few previous studies
(with a maximum follow-up of 1 year) up, will also be signiﬁcant pre-
dictors at 10 years follow-up. Therefore, we selected these predictors
as candidate predictors in this study.
2. Methods
2.1. Inclusion/Exclusion
The initial study population of this study was part of the RESEARCH
registry. The design of the RESEARCH registry has been published else-
where [19]. Brieﬂy, the RESEARCH registry is a single-center registryicle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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implantation in patients treated in daily clinical practice.
In this study, 1411 consecutive patients treated with PCI with im-
plantation of bare metal stents (BMSs) (October 2001 to April 2002)
or SES (April 2002 to October 2002) were included.2.2. Assessment procedure
For this study, of the 1411 patients, all surviving patients were
contacted by mail at 6 months (referred to as baseline in the remain-
der of the paper) and 10 years post-PCI. They were asked to complete
questionnaires about anginal status and medication usage, and the
36-item Short-Form Health Survey (SF-36), assessing subjective
health status. At each assessment moment, a reminder was sent to
patients who did not return their questionnaire. Only patients
(N = 1055) who did not die or were not lost over 10 years follow-
up were selected. The assessment at 6 months was chosen to ascer-
tain a stable medical condition. A similar approach has been adopted
in other studies of PCI patients [20].
Information about the in-hospital outcomes was obtained from our
hospital electronic clinical database maintained at our institution and
by reviewing the hospital records for those discharged to referring hos-
pitals. The survival status at each assessment moment was obtained
from theMunicipal Civil Registries. The referring physicians and institu-
tions were contacted whenever necessary for additional information.
This study was not subject to the Dutch Medical Research Involving
Human Subjects Act. Therefore, approval from the local research ethics
committee to conduct this retrospective follow-up study was not re-
quired at the time of enrollment. Moreover, the study was conducted
according to theHelsinki Declaration [21]. All patients consented partic-
ipation in this study.2.3. Baseline variables
Demographic variables included gender and age. Information about
clinical variables was prospectively collected at the time of the proce-
dure and recorded in the institutional database. Clinical variables in-
cluded hypertension, smoking, diabetes mellitus, family history of
CAD, indication for PCI, type of stent, previous myocardial infarction,
previous CABG, previous PCI, multi-vessel disease, and body mass
index [BMI]. Multivessel disease was deﬁned as PCI in more than one
coronary artery or in the leftmain. BMIwas categorized in three groups:
BMI b25 kg/m2, BMI 25–30 kg/m2 and BMI ≥30 kg/m2.2.4. Subjective health status
The subjective health statuswas assessedwith the SF-36 Health Sur-
vey. The SF-36 assesses 8 health status domains: physical functioning,
role limitations due to physical problems, bodily pain, general health,
social functioning, role limitations due to emotional functioning, mental
health, and vitality. The score range is from 0 to 100. A higher score on
the SF-36 sub domains represents an improved functioning; a high
score on the bodily pain scale indicates the absence of pain [22]. Good
reliability and validity have been reported for the Dutch version of the
SF-36, with Cronbach α ranging from 0.65 to 0.96 for all subscales [23].Fig. 1. Flowchart of patient selection.2.5. Outcome
The clinical end pointwas deﬁned as poor subjective health status at
10-year follow-up. As recommended by others [9,24], to enhance clini-
cal interpretability, we dichotomized the health status sub domains
into: poor health status (i.e. the lowest tertile) versus good health status
(i.e. the other two tertiles).2.6. Statistical analysis
Discrete variables were compared with the χ2 test and continuous
variables with Student t test. Univariable and multivariable logistic re-
gression analyses were done to examine the predictors of poor subjec-
tive health status for all of the eight health status subscales. Predictors
were ranked in a forward stepwise logistic regression model.
To determine predictors of poor subjective health status 10 years
post-PCI, analyses were done on data of those patients who completed
the SF-36 questionnaire at both baseline and 10 years post-PCI (N =
573). In multivariable analyses, we used all baseline characteristics,
and baseline SF-36 scores of the corresponding SF-36 sub domain. All
tests were 2-tailed, using a probability value of p b 0.05. For logistic re-
gression analyses, odds ratios (ORs) and their corresponding 95% conﬁ-
dence intervals (95% CIs) were reported. All data were analyzed using
SPSS 20.0 for Windows (SPSS Inc., Chicago, IL).
3. Results
3.1. Participants (ﬂow)
Fig. 1 shows the patientﬂow throughout the study. At the start of the
study, 1411 participants were contacted of whom 356 were lost during
10 years follow-up. Of these 356 patients, 322 died and 34 were lost to
follow-up. Of these 1055 eligible patients 573 patientsﬁlled in question-
naires at both baseline and 10 years post-PCI.
3.2. Baseline characteristics
Baseline characteristics of the 573 patients who responded at base-
line and 10 years vs. the 482 patients who did not respond at both base-
line and 10 years are listed in Table 1. Overall, between these two
groups, baseline characteristics are comparable, apart from three excep-
tions: patients who responded at both baseline and 10 years have lower
rate ofmultivessel disease (47% vs. 54%; p=0.021), lower rate of diabe-
tes mellitus (11% vs. 18%; p = 0.001), and their BMI is lower (27 ± 3.6






Patients who did not
respond at both
baseline and 10 years
P
No. of patients 573 482
Male 427 (75%) 342 (71%) 0.19
Age ± SD 60 ± 9.6 59 ± 11.6 0.33
Cardiovascular history
Previous MI 215 (38%) 165 (34%) 0.24
Previous CABG 50 (9%) 35 (7%) 0.38
Previous PCI 103 (18%) 105 (22%) 0.12
Multivessel disease 267 (47%) 259 (54%) 0.02
Risk factors
Hypertension 188 (33%) 167 (35%) 0.53
Family history 186 (33%) 162 (34%) 0.69
Current smoker 214 (37%) 201 (42%) 0.15
Diabetes mellitus 62 (11%) 85 (18%) 0.001
Body mass index 27 ± 3.6 28 ± 6.7 0.01
Indication for PCI 0.92
Stable angina 279 (49%) 229 (48%)
Unstable angina 198 (35%) 172 (36%)
Acute myocardial
infarction 96 (17%) 81 (17%)
Type of stent 0.75
Bare metal stent 298 (52%) 246 (51%)
Sirolimus-eluting stent 275 (48%) 236 (49%)
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post-PCI, baseline characteristics of the 34 patients who were lost to
follow-up did not differ signiﬁcantly, except for indication of PCI. Fur-
thermore, compared with the 1055 patients who were alive after
10 years follow-up, patients who died differed signiﬁcantly in all base-
line characteristics.
3.3. Predictors of poor subjective health status
Univariable analyses showed that SF-36 score at baseline signiﬁcant-
ly predicted all 8 sub domains, whereas acute myocardial infarction as
indication for PCI signiﬁcantly predicted 7 sub domains. Other signiﬁ-
cant predictors were gender, age, and previous PCI (all predicting 6
sub domains), obesity (predicting 5 sub domains), and smoking and di-
abetes mellitus (predicting 4 sub domains). (Appendix 1).
Multivariable analyses again showed that SF-36 at baseline signiﬁ-
cantly predicted all 8 sub domains. Age signiﬁcantly predicted 6 sub do-







functioning Bodily pain Genera
SF–36 at baseline 8,98 5,12 6,38 5,
5.35–15.07 3.16–8.30 4.11–9.92 3.68
Age 1,09 1,07 1,03
1.06–1.11 1.04–1.10 1.01–1.05




Indication PCIb: AMI 0,32 0,37
0.14–0.74 0.17–0.80
Diabetes Mellitus
Abbreviations: PCI, percutaneous coronary intervention; BMI, body mass index. AMI, acute my
Outcome measure: odds ratios and 95% CI. Darks cells indicate signiﬁcant results.
Predictors tested inmodel:male gender, age, hypertension, current smoker, diabetesmellitus, f
type of stent, SF-36 at baseline.
aReference: BMI b25. bReference: Indication PCI: stable angina pectoris.myocardial infarction as indication for PCI 2 sub domains, and diabetes
mellitus 1 sub domain. (Table 2).
4. Discussion
Besides the SF-36 scores at baseline, age and prior PCI were predic-
tors of a broad range of sub domains of subjective health status
10 years post-PCI. The SF-36 score at baseline signiﬁcantly predicted
all 8 sub domains of the SF-36. Thus SF-36 at baseline can be regarded
as a predictor of long-term subjective health status post-PCI.
Our results were partly similar to previous studies, which had a
shorter follow-up interval. These studies also found that baseline sub-
jective health status was an important predictor for health status post-
PCI [13,14,17,18]. In other studies, age predicted health status post-PCI
as well [13,17,18]. This was also found in studies with CABG patients
[25–30] or patientswith coronary artery disease [31]. Furthermore, obe-
sity and diabetes mellitus were previously found to be predictors of
health status [26–28,30,32]. However, this was not found in studies
that measured health status post-PCI.
In contrast with other studies [13,17] and with trends in the general
population [33], female gender was not a predictor of subjective health
status 10 years post-PCI. This result has not been previously found and is
hard to explain. In contrast, for CABG patients, gender was still predic-
tive for subjective health status, even after long follow-up duration
[25–27].
The results of this study have implication in clinical practice. Low SF-
36 score, older age, and prior PCIwere predictors of long-termpoor sub-
jective health. Both age and prior PCI could not be modiﬁed. However,
clinicians could be alert to thehealth status in these patients. In contrast,
the SF-36 score could be modiﬁed. First, patients have to get optimal
medical therapy. Optimalmedical therapy gives patients a better health
status [6,7,10]. Second, physical health status gets better by cardiac re-
habilitation [2]. So cardiologists have to refer their patients to cardiac re-
habilitation. Last, mental health status could be inﬂuenced by
psychosocial support of e.g. social workers.
The strength of this study is the long duration of follow-up and the
focus on post-PCI patients. This is theﬁrst study that determined predic-
tors of subjective health status 10 years post-PCI. Previous studies that
determined predictors of health status post-PCI had a maximum
follow-up duration of 1 year [13–17]. Furthermore, previous studies re-
ported on predictors of health status after acute coronary syndrome or
reported patients with coronary artery disease and not on post-PCI pa-





functioning Mental health Vitality
87 6,93 3,83 5,90 7,49










amily history, oldMI, previous CABG, previous PCI, multivessel disease, BMI, indication PCI,
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28 months [36].
Regarding CABG patients, several studies determined predictors of
health status [25–30,32,38–42]. Some studies had a follow-up duration
of several years [25–28,41]. Especially Herlitz et al. have studies with
long follow-up duration, with a maximum of 15 years [27]. This study
is therefore unique due to the 10 years' follow-up in PCI patients.
This study had several potential limitations. First, in this study two
types of stents were used: SES and BMS. Patients were not randomized
in regard of their type of stent. However, the strength of this study is
that no exclusion criterion was applied. This means that the study pop-
ulation was representative for the population in the daily practice of in-
terventional cardiology. To close the gap between research and clinical
practice, it has been advocated to conduct research in daily practice set-
tings [8]. Second, only 54% of the 1055 eligible patients responded on
the SF-36 at both baseline and 10 years post-PCI. It is a well-known
problem that there are many non-responders in a long registry. Other
studies have this problem aswell [25,26]. Third, baseline characteristics
of patients who responded at both baseline and 10 years post-PCI and
patients who did not respond at both baseline and 10 years post-PCI
were not completely similar. Responders had lower rate of multivessel
disease and diabetes mellitus, and they had a lower BMI. Fourth, there
may also be predictors that are not included in our analyses but that
have a predictive value.
Further studies with a comparable long-term follow-up interval are
needed to replicate ourﬁndings in order to develop a framework of pre-
dictors of long-term subjective health status after PCI.
In conclusion, we found that SF-36 scores at baseline, age, and previ-
ous PCI are signiﬁcant predictors of subjective health status 10 years
post-PCI. Assessment of health status at baseline is a useful indicator
to predict long-term subjective health status.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.ijcha.2016.03.011.
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